The global multimodal imaging market size was estimated to be USD 4.67 billion in 2023 and is expected to reach at USD 8.88 billion by 2034 with a CAGR of 6.02% during the forecast period 2024-2034. Increasing prevalence of chronic diseases, rising geriatric population, growing advancements in the diagnostic imaging such as using artificial intelligence in CT scans, surge in health expenditure, increasing adoption of advanced tools & equipment comprising multimodal imaging systems for diagnostics and research applications, rising research & development activities, and growing investment by major market players for the incorporation of artificial intelligence in CT systems are some of the key factors boosting the market growth.
Growing investment by major market players for the incorporation of artificial intelligence in CT systems is predicted to boost the market growth during the forecast period. The implementation and maintenance of AI technology for multimodal imaging systems demand a large expenditure. For instance, in May 2023, St. Luke's University Health Network has selected GE Healthcare to make a $30 million investment in cutting-edge CT technology infused with Artificial Intelligence capabilities.
By technology, PET/CT system was the highest revenue-grossing segment in the global multimodal imaging market in 2023 owing to rising adoption for the diagnosis of malignancies, growing demand for early & accurate cancer diagnosis, increasing the use of PET/CT systems in cardiology, and surge in technological improvements in the field of PET/CT. For instance, in June 2023, Siemens Healthineers has introduced the Biograph Vision.X, an FDA-pending PET/CT scanner that enhances the existing capabilities of the Biograph Vision. This new scanner offers a time of flight (TOF) of 178 picoseconds (ps), which the company claims is the fastest TOF in the industry. Additionally, SPECT/CT system is predicted to grow at fastest CAGR during the forecast period owing to the greater sensitivity, improved image clarity, & a larger selection of radiotracers, increasing demand for single-photon emission computed tomography (SPECT), rising adoption in nuclear medicine.
By application, brain & neurology was the highest revenue-grossing segment in the global multimodal imaging market in 2023 owing to surge in number of radiology centers, increasing use of multimodal for general imaging & diagnosis purpose, growing research & development activities, and rising research & development activities. For instance, in September 2022, Corindus, a company under Siemens Healthineers specializing in precision vascular robotics, has shared the findings of a pioneering study that establishes the safety and efficacy of using the CorPath GRX Neurovascular System for robotic-assisted neurovascular aneurysm embolization. Additionally, oncology is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for diagnosis, staging, therapy planning, & treatment response monitoring of cancer, growing prevalence of cancer, and surge in demand & widespread usage of multimodal imaging methods in cancer care.
By end-user, hospitals was the highest revenue-grossing segment in the global multimodal imaging market in 2023 owing to the primary healthcare institutions that significantly depend on multimodal imaging technologies for a range of diagnostic & therapeutic goals, surge in prevalence of chronic diseases, and increasing launch of advanced systems. For instance, In May 2022, FUJIFILM VisualSonics Inc., a prominent supplier of photoacoustic and high-frequency ultrasound imaging systems, has introduced a multi-modal imaging system with a broad range of ultrasound frequencies, from ultra-high to low. Known as Vevo F2, this system is designed for preclinical applications, featuring advanced image processing capabilities that surpass the performance of its predecessors. Additionally, diagnostic centers is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for diagnostic imaging & offer multimodal imaging services regularly to people referred by doctors or other healthcare experts and surge in collaborations within market players.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising well-established insurance policies, growing prevalence of chronic diseases, surge in advanced healthcare infrastructure, increasing number of geriatric populations, rapid adoption of technologically advanced imaging systems, and growing launch of advanced systems. For instance, In June 2022, Siemens Healthineers, a division of Siemens AG, has introduced the Biograph Vision PET/CT system, which includes a reduced number of crystal elements. This design enhancement aims to enhance spatial resolution, ultimately leading to improved detection of lesions in cancer diagnosis. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare investments, growing medical tourism, surge in better healthcare infrastructure, increasing prevalence of chronic illnesses, rising healthcare innovations, growing adoption of multimodal imaging methods, and surge in collaborations within market players. For instance, in February 2023, The expanded collaboration between GE Healthcare and Sinopharm is centered on creating and marketing medical equipment tailored to address China's unique healthcare needs.
Growing investment by major market players for the incorporation of artificial intelligence in CT systems is predicted to boost the market growth during the forecast period. The implementation and maintenance of AI technology for multimodal imaging systems demand a large expenditure. For instance, in May 2023, St. Luke's University Health Network has selected GE Healthcare to make a $30 million investment in cutting-edge CT technology infused with Artificial Intelligence capabilities.
By technology, PET/CT system was the highest revenue-grossing segment in the global multimodal imaging market in 2023 owing to rising adoption for the diagnosis of malignancies, growing demand for early & accurate cancer diagnosis, increasing the use of PET/CT systems in cardiology, and surge in technological improvements in the field of PET/CT. For instance, in June 2023, Siemens Healthineers has introduced the Biograph Vision.X, an FDA-pending PET/CT scanner that enhances the existing capabilities of the Biograph Vision. This new scanner offers a time of flight (TOF) of 178 picoseconds (ps), which the company claims is the fastest TOF in the industry. Additionally, SPECT/CT system is predicted to grow at fastest CAGR during the forecast period owing to the greater sensitivity, improved image clarity, & a larger selection of radiotracers, increasing demand for single-photon emission computed tomography (SPECT), rising adoption in nuclear medicine.
By application, brain & neurology was the highest revenue-grossing segment in the global multimodal imaging market in 2023 owing to surge in number of radiology centers, increasing use of multimodal for general imaging & diagnosis purpose, growing research & development activities, and rising research & development activities. For instance, in September 2022, Corindus, a company under Siemens Healthineers specializing in precision vascular robotics, has shared the findings of a pioneering study that establishes the safety and efficacy of using the CorPath GRX Neurovascular System for robotic-assisted neurovascular aneurysm embolization. Additionally, oncology is predicted to grow at fastest CAGR during the forecast period owing to the increasing demand for diagnosis, staging, therapy planning, & treatment response monitoring of cancer, growing prevalence of cancer, and surge in demand & widespread usage of multimodal imaging methods in cancer care.
By end-user, hospitals was the highest revenue-grossing segment in the global multimodal imaging market in 2023 owing to the primary healthcare institutions that significantly depend on multimodal imaging technologies for a range of diagnostic & therapeutic goals, surge in prevalence of chronic diseases, and increasing launch of advanced systems. For instance, In May 2022, FUJIFILM VisualSonics Inc., a prominent supplier of photoacoustic and high-frequency ultrasound imaging systems, has introduced a multi-modal imaging system with a broad range of ultrasound frequencies, from ultra-high to low. Known as Vevo F2, this system is designed for preclinical applications, featuring advanced image processing capabilities that surpass the performance of its predecessors. Additionally, diagnostic centers is predicted to grow at fastest CAGR during the forecast period owing to the rising demand for diagnostic imaging & offer multimodal imaging services regularly to people referred by doctors or other healthcare experts and surge in collaborations within market players.
North America region is anticipated for the highest revenue share during the forecast period owing to the rising well-established insurance policies, growing prevalence of chronic diseases, surge in advanced healthcare infrastructure, increasing number of geriatric populations, rapid adoption of technologically advanced imaging systems, and growing launch of advanced systems. For instance, In June 2022, Siemens Healthineers, a division of Siemens AG, has introduced the Biograph Vision PET/CT system, which includes a reduced number of crystal elements. This design enhancement aims to enhance spatial resolution, ultimately leading to improved detection of lesions in cancer diagnosis. Additionally, Asia Pacific region is predicted to grow at fastest CAGR during the forecast period owing to the rising healthcare investments, growing medical tourism, surge in better healthcare infrastructure, increasing prevalence of chronic illnesses, rising healthcare innovations, growing adoption of multimodal imaging methods, and surge in collaborations within market players. For instance, in February 2023, The expanded collaboration between GE Healthcare and Sinopharm is centered on creating and marketing medical equipment tailored to address China's unique healthcare needs.
Segmentation: Multimodal Imaging Market Report 2022 - 2033
Multimodal Imaging Market Analysis & Forecast by Technology 2023 - 2034 (Revenue USD Bn)
- SPECT/CT Systems
- PET/MR Systems
- PET/CT Systems
- Others
Multimodal Imaging Market Analysis & Forecast by Application 2023 - 2034 (Revenue USD Bn)
- Ophthalmology
- Brain & Neurology
- Cardiology
- Oncology
- Others
Multimodal Imaging Market Analysis & Forecast by End-user 2023 - 2034 (Revenue USD Bn)
- Diagnostic Centers
- Hospitals
- Others
Multimodal Imaging Market Analysis & Forecast by Region 2023 - 2034 (Revenue USD Bn)
North America
- U.S.
- Canada
Europe
- Germany
- France
- UK
- Spain
- Italy
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- Australia
- South Korea
- Rest of APAC
Latin America
- Brazil
- Mexico
- Argentina
- Rest of LATAM
Middle East & Africa
- South Africa
- GCC
- Rest of MEA
Table of Contents
1. Research Methodology
2. Introduction
4. Market Environment Analysis
5. Market Dynamics
7. Multimodal Imaging Market: Technology Estimates & Trend Analysis
8. Multimodal Imaging Market: Application Estimates & Trend Analysis
9. Multimodal Imaging Market: End-user Estimates & Trend Analysis
10. Regional Market Analysis
11. North America Multimodal Imaging Market
12. Europe Global Multimodal Imaging Market
13. Asia Pacific Global Multimodal Imaging Market
14. Latin America Global Multimodal Imaging Market
15. MEA Global Multimodal Imaging Market
16. Competitor Analysis
17. Company Profiles
Companies Mentioned
- GE Healthcare
- Bartec Technologies Ltd
- Siemens Healthineers
- United Imaging Healthcare CO.
- Koninklijke Philips N.V.
- Canon Inc
- Mediso Ltd.
- IBM Corporation
- Neusoft Medical Systems Co. Ltd
- Bruker Corporation
- Neusoft Medical Systems Co. Ltd
- Spectrum Dynamics Medical
- MILabs B.V.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 145 |
| Published | October 2023 |
| Forecast Period | 2023 - 2034 |
| Estimated Market Value ( USD | $ 4.67 Billion |
| Forecasted Market Value ( USD | $ 8.88 Billion |
| Compound Annual Growth Rate | 6.0% |
| Regions Covered | Global |
| No. of Companies Mentioned | 13 |
